News
AIMS Institute Integrative Medicine Residency Program — this is a new video by Drs. Standish and Aggarwal describing the AIMS Institute ND residency program, that has just begun its …
Healing Maps is a directory of psychedelic therapy clinics and retreats, as well as an educational source for this emerging industry. We receive over 250,000 unique visitors each month. …
Dr. Aggarwal and AIMS Institute’s effort to secure psilocybin under the Right-To-Try laws for our patients is featured in the current issue of Time magazine. Dying Patients Are Fighting …
by Dan Vinkovetsky aka Danny Danko: I spoke with Dr. Alison Draisin PsyD, LMHC, lead psychotherapist and Director of Ketamine Assisted Psychotherapy Provider Training at the AIMS Institute, to …
AIMS Institute’s work with Right-To-Try access to psilocybin for its patients is covered in a feature story in the August 2022 issue of the ABA Journal, the flagship publication …
by Larry Beserford featuring Dr. AIMS Institute Co-Director, Dr. Aggarwal appears online today in a special issue of the Cannabis Science & Technology website. CLICK HERE TO SEE THE …
A short documentary film from last week with footage of the May 9th demonstration at DEA Headquarters. The film produced by Susan Rockefeller is brief and excellent can be …
The effort to legalize magic mushrooms as a treatment option for the mental health care crisis is growing in Washington. Oregon voters legalized psilocybin, the active ingredient in hallucinogenic …
It is rare for a week to go by without a newly published study on psychedelics in peer-reviewed medical journals. Psychedelics (e.g., cannabis, ketamine, psilocybin, and ayahuasca) are becoming …
Studies at prestigious research institutions around the world are showing compelling results for psychedelics as treatments for serious mental health and substance use disorders when administered in clinical settings …
An update on the state of science for psychedelics, and what all clinicians should know as they enter this uncharted territory. Articles about psychedelic treatments for persistent depression, PTSD, …
Date: February 3, 2022 Landmark Petition to Reschedule Psilocybin filed with DEA View PDF Bipartisan Congressional support for allowing terminal patients to seek relief from anxiety and depression in …
Bipartisan members of Congress sent a letter on Tuesday requesting that the Drug Enforcement Administration (DEA) allow terminally ill patients to use psilocybin as an investigational treatment without the …
The Advanced Integrative Medical Science (AIMS) Institute in Seattle is a multi-specialty teaching clinic and research institute founded in 2018 offering cutting edge care in oncology, psychiatry, neurology, rehabilitation, …
11/11/2021 Fellows of the American Academy of Hospice and Palliative Medicine One of the highest honors the Academy can bestow on an AAHPM member is recognized as a Fellow …
Along with Washington Insurance Commissioner Mike Kreidler, Dr. Aggarwal was a guest speaker at the 2021 End of Life Washington Annual Meeting held October 16th, 10:30 – 11:50 AM. …
Ketamine-assisted Psychotherapy / AIMS vs. DEA – Part 2 Also Published on ProjectCBD.ORG
2021.11.01 | GZJ 海外動向 | by greenzonejapan https://www.greenzonejapan.com/2021/11/01/ketamin-aims-vs-dea-1/ You might have heard a term “Psychedelic Renaissance.” In the West, research into the use of hallucinogens such as psilocybin, LSD and MDMA to treat mental …
CLICK HERE TO LISTEN Janette: Welcome to GW Integrative Medicine, the podcast about disease prevention and health promotion from the Office of Integrative Medicine and Health at the George …
Is now out! Written as a joint project between SMJ Consulting’s Educators Mary Brown and Jessica Streufert, with AIMS Institute physicians Sunil Aggarwal and Sonia Malani.
We’re in Reuters: https://www.reuters.com/legal/litigation/week-ahead-health-aug-30-2021-2021-08-27/ Thursday, Sept. 2 1 p.m. – The 9th U.S. Circuit Court of Appeals will hear a challenge to the Drug Enforcement Administration’s determination in February …
Our team member, Sonia Malani, ND, FABNO was recently interviewed on a podcast titled Here For Healing! Click the links below to listen. Podcast Creator: Carly Brown (Instagram is …
Shariq Mansoor Khan1*, Gregory T. Carter2, Sunil K. Aggarwal3 and Julie Holland4 1Washington University School of Medicine in St. Louis, St. Louis, MO, United States 2Department of Physical Medicine & Rehabilitation, St. Luke’s …
AIMS Co-Founder and Director Dr. Sunil Aggarwal’s new chapter entitled Deep Respect After Profound Neglect: Spiritual Health and Safety for Use of Cannabis and Other Entheogens in an Integrative …
Our team here at AIMS Institute would like to offer our congratulations to Dr. Malani for receiving her American Board of Naturopathic Oncology certification! This achievement is held by …
Imagine you have a terminal illness. You hear how a psilocybin session could help you make peace with death so that you can perhaps enjoy your remaining days on Earth. …
https://www.rollingstone.com/culture/culture-features/psychedelics-death-anxiety-psilocybin-1184240/ “I need to be in a space where I am not hopeless,” says one terminal cancer patient who is suing the Justice Department and the DEA for her …
Why This Physician Is Suing the DEA Over Psilocybin How Psilocybin and Ketamine Are Helping Terminally Ill Patients Entheogens: The Spiritual Side of Psychedelic Medicine Eye-Opening Insights on The …
https://oncanp.org/conference/ On June 12, Dr. Giles presented virtually the following oral presentation: Ketamine assisted psychotherapy (KAP) in the context of advanced cancer diagnosis, treatment, progression and remission The abstract’s …
Mary Brown of SMJ Consulting invited AIMS Institute Co-Directors Drs. Aggarwal and Standish to participate in this sponsored article about the gains that cannabis made in the medical community …
Sunil Aggarwal, MD, PhD, FAAPMR is a Board-Certified Physician in Hospice and Palliative Medicine and Physical Medicine and Rehabilitation and Medical Geographer and serves as the Past Chair of …
MAY 24, 2021 BY MJ NEWS NETWORK https://mjnewsnetwork.com/business/curts-conversation-with-cannabinologist-dr-sunil-kumar-aggarwal/NO DISCUSSION YET CURT’S CANNABIS CORNER Conversation with “Cannabinologist” Dr. Sunil Kumar Aggarwal By Curt Robbins Welcome to this week’s installation of Curt’s Cannabis …
By Ben Adlin https://www.marijuanamoment.net/8-states-side-with-cancer-patients-in-psilocybin-mushroom-lawsuit-against-dea/ A bipartisan group of attorneys general from eight U.S. states and the District of Columbia has sided with cancer patients in a lawsuit against the …
PORT TOWNSEND LEADER “Officials say criminal cases of psychedelic drug use are uncommon, but local legalization remains unlikely” Posted Friday, May 14, 2021 9:54 am Dr. Sunil Aggarwal, co-founder …
If you have any problems please click this link: https://www.youtube.com/watch?v=Y1uteoNxBEg The Cannabis Alliance Sunil Kumar Aggarwal, M.D, AIMS Institute Lukas Barfield, Patient Mary Brown, SMJ Consulting Alison Draison, PsyD, …
Damocles’ syndrome revisited: Update on the fear of cancer recurrence in the complex world of today’s treatments and survivorship Margaret Cupit-Link 1, Karen L Syrjala 2, Shahrukh K Hashmi 3 Affiliations expand PMID: 29476707 PMCID: PMC6098978 DOI: 10.1016/j.hemonc.2018.01.005 …
Cancer Wellness School is a two-day online seminar. The content of this course is an adjunct to medical treatment meant to enhance and support, not replace, conventional medicine. We …
Did you know that naturopathic doctors are not covered by Medicare? If you are or will soon be Medicare eligible, take a few minutes to share why you don’t …
CLICK HERE TO LISTEN The collective perception of psychedelics is that they are simply best utilized for tripping balls, but the reality is they offer a wide range of …
The conference this Sunday 4/25/21 at 3:10pm PST on “The Medicalization of Ayahuasca: Promises, Challenges, and Reciprocity” A Virtual Psychedelic Summit on the Globalization of Plant Medicines and …
Scroll down below for link to video and slide deck. Save the Date: 4/6/21 at 8am, AIMS Co-Director Dr. Aggarwal will be giving a virtual presentation as part of …
Peer-reviewed paper recently published looking at psychomotor performance with real-time cannabis use data conducted in part at AIMS Institute. We are excited to haven been chosen as a site …
Save the Date: 4/21/21 at 7pm, AIMS Co-Director Dr. Standish will be giving a virtual presentation as part of Vashon Center for the Arts “Talks on the Rocks”. Stay …
We at AIMS enjoyed this British Medical Journal blog piece very much, finding it to be an important integrative bridge perspective. One of my adult sons asked me if I …
We have taken an additional step recently in our effort to secure psilocybin therapeutic use for two of our cancer patients under State and Federal Right to Try (RTT) …
I gave an interview for a psychology podcast by produced by University of Washington undergraduate students recently🎓🌾🔍 Psychedelics: Part 2
Watch the Panel recently hosted at the UW Law School Center for Law in Science & Global Health on the Right To Try effort as a means to open …
AIMS Co-Founder and Co-Director Dr Aggarwal served as an invited Guest Faculty in which he described his research and perspectives on the topic of Cannabis and Cancer at this …
Drug reform advocates won big in Oregon this year, with separate ballot measures to decriminalize possession of all drugs and legalize psychedelic mushrooms for therapeutic use passing on Election …
“For a long time, I wasn’t interested in ketamine,” Sunil Aggarwal, MD, PhD explained. “But I started using it because it’s one of the only above-board psychedelics.” Typically, ketamine …
